SUZANNE ANDERS: Open Payments
NPI 1750773958 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 17 payments from 7 companies in 2025. Trend: 2023 $783 · 2024 $2,750 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| BridgeBio Pharma, Inc. | 1 | $109 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| PFIZER INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Attruby, LEQVIO, FARXIGA, CAMZYOS, ENTRESTO, VERQUVO, VYNDAQEL, Wegovy.
Industry payments across WA — which companies pay providers there.
